The Beauty Health Company (SKIN)
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.15 per share a year ago.
Fast-paced Momentum Stock Beauty Health (SKIN) Is Still Trading at a Bargain
Beauty Health (SKIN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
International Markets and Beauty Health (SKIN): A Deep Dive for Investors
Examine the evolution of Beauty Health's (SKIN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
The Beauty Health Company (SKIN) Q2 2025 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Marla Malcolm Beck - President, CEO & Director Michael P. Monahan - Chief Financial Officer Conference Call Participants Alec Edward Legg - Canaccord Genuity Corp., Research Division Bruce David Jackson - The Benchmark Company, LLC, Research Division Joseph Paul Federico - Stifel, Nicolaus & Company, Incorporated, Research Division K.
Beauty Health (SKIN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Beauty Health (SKIN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Beauty Health Company (SKIN) Surpasses Q2 Earnings and Revenue Estimates
The Beauty Health Company (SKIN) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to a loss of $0.1 per share a year ago.
The Beauty Health Company (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beauty Health (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Fast-paced Mover Beauty Health (SKIN) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Beauty Health (SKIN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Beauty Health (SKIN) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Beauty Health (SKIN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Beauty Health (SKIN) Reliance on International Sales: What Investors Need to Know
Explore Beauty Health's (SKIN) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
The Beauty Health Company (SKIN) Q1 2025 Earnings Conference Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Norberto Aja - IR Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Susan Anderson - Canaccord Genuity Jon Block - Stifel Olivia Tong - Raymond James Bruce Jackson - Benchmark Company Navann Ty - BNP Paribas Operator Good day, everyone, and welcome to today's Beauty Health Company First Quarter 2025 Earnings Call. At this time all participants are in a listen-only mode.
Beauty Health (SKIN) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Beauty Health (SKIN) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
